Order Article Reprints

Saad HKM, Abd Rahman AA, Ab Ghani AS, Taib WRW, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN. Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. Biomedicines. 2022; 10(1):189. https://doi.org/10.3390/biomedicines10010189

Saad, Hanan Kamel M., Alawiyah Awang Abd Rahman, Azly Sumanty Ab Ghani, Wan Rohani Wan Taib, Imilia Ismail, Muhammad Farid Johan, Abdullah Saleh Al-Wajeeh, and Hamid Ali Nagi Al-Jamal. 2022. "Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients" Biomedicines 10, no. 1: 189. https://doi.org/10.3390/biomedicines10010189

Saad, H. K. M., Abd Rahman, A. A., Ab Ghani, A. S., Taib, W. R. W., Ismail, I., Johan, M. F., Al-Wajeeh, A. S., & Al-Jamal, H. A. N. (2022). Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. Biomedicines, 10(1), 189. https://doi.org/10.3390/biomedicines10010189